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Objective 
 
To prospectively measure flow mediated 
vasodilation (FMD) in a cohort of women 
with risk factors for preeclampsia and to 
identify poor obstetrical outcomes 
associated with changes in FMD. 
Methods  
Data from 34 participants enrolled in this 
prospective cohort trial were analyzed. 
Brachial artery FMD was evaluated and 
recorded by a trained research nurse for 
each participant in each trimester of 
pregnancy. Demographic data and 
pregnancy outcome data were obtained 
from the electronic medical record. The 
data was analyzed and a backward, 
stepwise regression was used to create 
the final model. 
Results 
The cohort FMD, overall, did not 
significantly change during pregnancy. 
Significant correlations between FMD 
and pregnancy characteristics included 
extremes of maternal age, age at time of 
delivery, operative vaginal delivery, 
PPROM, abruption and history of 
preeclampsia. Significant correlations 
between the change in FMD between 
trimesters and pregnancy characteristics 
included extremes of maternal age, BMI 
over 25, type I diabetes mellitus, 
number of live births and age at the time 
of delivery. A decrease in FMD was 
found to be significantly predictive of the 
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development of gestational diabetes 
mellitus type A1 in this cohort (p=0.03). 
Conclusion 
This is the first study to prospectively 
evaluate FMD in a cohort at risk for 
developing pre-eclampsia. The change 
in FMD from the first to the second 
trimester is predictive of GDMA1. This 
change suggests a predictive modality 
and early pathophysiologic pathway in 
the development of adverse outcomes 
in this cohort of women. 
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